As of Nov 13, 2026. At least 3 observations, ranked by Alpha IQ over 21 trading days. 1,918 eligible records before the optional luck filter.
Link an account to see your stake.
#1 Opaleye Management Inc.
72 buys · 9 sales · 21 trading days
Alpha IQ90.1
Why this rank?
59 of 81 worked
Unlikely under model
Unlikely under the luck model.
This rank comes from 72 purchases and 9 sales, measured over 21 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
132 trade dates · 18 nonoverlapping windows · 7 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought CDXSApr 8, 2025$198,380
Stock +6.5%; recorded comparison +23.4%; outcome in the trade's direction -17.0%.
1 reported line and filing sources
Apr 8, 2025 · $198,380 · Form 4Stock +6.5% versus the recorded factor comparison +23.4%.
Bought CDXSApr 30, 2025$57,660
Stock -7.1%; recorded comparison +3.1%; outcome in the trade's direction -10.3%.
1 reported line and filing sources
Apr 30, 2025 · $57,660 · Form 4Stock -7.1% versus the recorded factor comparison +3.1%.
Bought HROWApr 23, 2024$120,547
Stock +70.4%; recorded comparison +45.3%; outcome in the trade's direction +25.1%.
1 reported line and filing sources
Apr 23, 2024 · $120,547 · Form 4Stock +70.4% versus the recorded factor comparison +45.3%.
Bought CDXSMar 20, 2025$236,284
Stock -25.7%; recorded comparison -8.8%; outcome in the trade's direction -16.9%.
2 reported lines and filing sources
Mar 20, 2025 · $18 · Form 4Stock -25.7% versus the recorded factor comparison -8.8%.
Mar 21, 2025 · $236,266 · Form 4Stock -25.7% versus the recorded factor comparison -8.8%.
Bought CDXSMar 13, 2025$216,155
Stock -17.3%; recorded comparison -16.6%; outcome in the trade's direction -0.7%.
1 reported line and filing sources
Mar 13, 2025 · $216,155 · Form 4Stock -17.3% versus the recorded factor comparison -16.6%.
Bought SLGLNov 24, 2025$37,933
Stock +9.5%; recorded comparison +1.2%; outcome in the trade's direction +8.3%.
2 reported lines and filing sources
Nov 26, 2025 · $37,720 · Form 4Stock +9.5% versus SPY +1.2%.
Nov 24, 2025 · $213 · Form 4Stock +9.5% versus SPY +1.2%.
Bought CDXSJul 29, 2025$28,161
Stock +1.9%; recorded comparison +3.4%; outcome in the trade's direction -1.6%.
2 reported lines and filing sources
Jul 30, 2025 · $4,411 · Form 4Stock +1.9% versus the recorded factor comparison +3.4%.
Jul 29, 2025 · $23,750 · Form 4Stock +1.9% versus the recorded factor comparison +3.4%.
Bought HROWNov 15, 2023$200,735
Stock +14.9%; recorded comparison +21.0%; outcome in the trade's direction -6.1%.
1 reported line and filing sources
Nov 15, 2023 · $200,735 · Form 4Stock +14.9% versus the recorded factor comparison +21.0%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001595855. Profile company CIK 0001417663. SANUWAVE Health, Inc.
Recorded role: 10% Owner · SNVW.
81 obs. Confidence 100; 21-day hit rate 72.8%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 121.3):
Past calls: 58% directionally correct over 3 months (adjusted toward 50% peer prior; 59% observed; recency-weighted sample 121.3)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 58 of 78 represented trade dates; upper tail 1.648e-7; corrected within the horizon 1.009e-3, across 24734 person/horizon comparisons 1.359e-3. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 18 windows, with 12 wins and upper tail 6.011e-2.
One entry per filing selected from the current 90-day scored feed. Derivatives and known open-market trades below $10,000 are excluded from conviction scoring. These are reported transactions, not live trades. A trade score and an insider's historical Alpha IQ measure different things.